Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation
- PMID: 16889599
- DOI: 10.1111/j.1600-6143.2006.01488.x
Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation
Abstract
Absolute and human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T-cell counts were monitored in 38 solid organ (20 heart, 9 lung and 9 kidney) transplant recipients during the first year after transplantation by a novel assay based on T-cell stimulation with HCMV-infected autologous dendritic cells. According to the pattern of T-cell restoration occurring either within the first month after transplantation or later, patients were classified as either early (n = 21) or late responders (n = 17). HCMV-specific CD4+ and CD8+ T-cell counts were consistently lower in late compared to early responders from baseline through 6 months after transplantation. In addition, in late responders, while HCMV infection preceded immune restoration, HCMV-specific CD4+ restoration was significantly delayed with respect to CD8+ T-cell restoration. The number of HCMV-specific CD4+ and CD8+ T-cells detected prior to transplantation significantly correlated with time to T-cell immunity restoration, in that higher HCMV-specific T-cell counts predicted earlier immune restoration. Clinically, the great majority of early responders (18/21, 85.7%) underwent self-resolving HCMV infections (p = 0.004), whereas the great majority of late responders (13/17, 76.5%) were affected by HCMV infections requiring antiviral treatment (p = <0.0001). Simultaneous monitoring of HCMV infection and HCMV-specific T-cell immunity predicts T-cell-mediated control of HCMV infection.
Similar articles
-
Reconstitution of Human Cytomegalovirus-Specific CD4+ T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection.Biol Blood Marrow Transplant. 2015 Dec;21(12):2192-2202. doi: 10.1016/j.bbmt.2015.08.002. Epub 2015 Aug 8. Biol Blood Marrow Transplant. 2015. PMID: 26260678
-
Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients.J Clin Virol. 2014 Sep;61(1):65-73. doi: 10.1016/j.jcv.2014.05.017. Epub 2014 Jun 4. J Clin Virol. 2014. PMID: 24961915
-
Immune Control of Human Cytomegalovirus (HCMV) Infection in HCMV-Seropositive Solid Organ Transplant Recipients: The Predictive Role of Different Immunological Assays.Cells. 2024 Aug 8;13(16):1325. doi: 10.3390/cells13161325. Cells. 2024. PMID: 39195215 Free PMC article.
-
Measurement of anti-human cytomegalovirus T cell reactivity in transplant recipients and its potential clinical use: a mini-review.Intervirology. 1999;42(5-6):322-4. doi: 10.1159/000053967. Intervirology. 1999. PMID: 10702713 Review.
-
The CD4+ T Cell Response to Human Cytomegalovirus in Healthy and Immunocompromised People.Front Cell Infect Microbiol. 2020 May 19;10:202. doi: 10.3389/fcimb.2020.00202. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32509591 Free PMC article. Review.
Cited by
-
Assessing Anti-HCMV Cell Mediated Immune Responses in Transplant Recipients and Healthy Controls Using a Novel Functional Assay.Front Cell Infect Microbiol. 2020 Jun 26;10:275. doi: 10.3389/fcimb.2020.00275. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32670891 Free PMC article.
-
Human cytomegalovirus-specific T-cell immune reconstitution in preemptively treated heart transplant recipients identifies subjects at critical risk for infection.J Clin Microbiol. 2012 Jun;50(6):1974-80. doi: 10.1128/JCM.06406-11. Epub 2012 Mar 29. J Clin Microbiol. 2012. PMID: 22461674 Free PMC article.
-
Modified vaccinia Ankara expressing EEHV1A glycoprotein B elicits humoral and cell-mediated immune responses in mice.PLoS One. 2022 Mar 21;17(3):e0265424. doi: 10.1371/journal.pone.0265424. eCollection 2022. PLoS One. 2022. PMID: 35312707 Free PMC article.
-
Management of cytomegalovirus infection in solid organ transplantation.Nat Rev Nephrol. 2010 Dec;6(12):711-21. doi: 10.1038/nrneph.2010.141. Epub 2010 Oct 26. Nat Rev Nephrol. 2010. PMID: 20978468 Review.
-
Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy.J Clin Virol. 2012 May;54(1):56-60. doi: 10.1016/j.jcv.2012.01.015. Epub 2012 Mar 10. J Clin Virol. 2012. PMID: 22410132 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials